FIELD: medicine.
SUBSTANCE: ablation is preceded by saturating a corneal stroma with riboflavin. After the ablation, the stroma is saturated with emoxipine. These procedures use 0.1% or 0.25% riboflavin, 1% emoxipine. The saturation represents instilling the solution every 1-2 minutes or spraying it in aerosol after dispersed by an ultrasonic nebuliser using a continuous or intermittent aerosol delivery at interval and duration 5-60 seconds.
EFFECT: method enables protecting the cells in cross-linking and ablation manipulations.
5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NSAIDS APPLICATION IN EXCIMER LASER CORNEAL SURGERY | 2015 |
|
RU2612810C2 |
| METHOD FOR ASSESSING PHOTOPROTECTIVE CORNEAL PROPERTIES | 2015 |
|
RU2581951C1 |
| METHOD FOR ASSESSING TOLERANCE OF MEDICATIONS DURING EPIBULBAR USE THEREOF | 2015 |
|
RU2604711C1 |
| METHOD OF TREATING KERATOCONUS, INCLUDING IN PATIENTS WITH CORNEAL THICKNESS OF LESS THAN 450 MICRONS, USING ULTRAVIOLET CROSS-LINKING OF CORNEAL COLLAGEN IN COMBINATION WITH PERSONALIZED TRANSEPITHELIAL PHOTOREFRACTIVE KERATECTOMY | 2023 |
|
RU2814093C1 |
| METHOD OF CORRECTING AMETROPIA IN PATIENTS WITH STAGE I KERATOCONUS | 2023 |
|
RU2801483C1 |
| METHOD FOR AFTER-CORRECTING RESIDUAL MYOPIC AMETROPIA AFTER PREVIOUS KERATOREFRACTIVE OPERATIONS | 2022 |
|
RU2786592C1 |
| METHOD OF TREATING PROGRESSIVE KERATOCONUS | 2017 |
|
RU2685658C1 |
| METHOD OF EPITHELIAL REMOVAL IN PHOTOREFRACTIVE AND PHOTOTHERAPEUTIC OPERATIONS ON CORNEA | 2018 |
|
RU2718260C1 |
| METHOD FOR KERATOCONUS TREATMENT | 2016 |
|
RU2620757C1 |
| METHOD FOR RESTORATION OF VISUAL FUNCTIONS IN PATIENTS WITH MILD MYOPIA COMBINED WITH CORNEAL KERATOCONUS | 2022 |
|
RU2820962C2 |
